ATH 25.0% 0.5¢ alterity therapeutics limited

Ira Shoulson is on the BOD and he is founder of the HSG. He left...

  1. 1,847 Posts.
    lightbulb Created with Sketch. 1
    Ira Shoulson is on the BOD and he is founder of the HSG. He left his position at HSG to allow him to focus efforts on helping to bring PBT2 to market. Perhaps it’s a good time to revisit the interview with Ira when he joined the BOD of Prana -

    http://www.brrmedia.com/event/123434/

    "It’s important to complete the process…Well, from my vantage point it was a Phase 2 trial that exceeded expectations. The expectation was that it would show that PBT2 at 2 dosages…would be safe and well tolerated and indeed that was the case. What exceeded the expectations was also we received in analyzing the data a signal of benefit for patients on especially the highest dose of PBT2 and that benefit was one of improved cognitive intellectual performance and that this trend was translated into a slowing of decline in their functions.”
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.001(25.0%)
Mkt cap ! $26.19M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $27.94K 6.050M

Buyers (Bids)

No. Vol. Price($)
46 57663299 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 56205001 43
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
0.5¢
  Change
0.001 ( 0.00 %)
Open High Low Volume
0.5¢ 0.5¢ 0.5¢ 20524121
Last updated 15.46pm 29/03/2024 ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.